Podcast - States Propose New Laws Affecting Healthcare Real Estate Investors and Owners
Hospice Insights Podcast - PPEO Playbook: The High-Stakes Game Hospices Can’t Afford to Lose
Podcast - Assessing the State of Healthcare Restructurings
Leaders in Law: Life Sciences and Technology Transactions with Jekkie Kim
Health-e Law Podcast, Episode 22 | J.P. Morgan Healthcare 2026 and Beyond: Regulation, Technology and the Future of Health Equity
Podcast — Spotlight on US State Healthcare Transaction Review Laws
Taking the Pulse: A Health Care and Life Sciences Video Podcast | Episode 268: Inside South Carolina’s Life Sciences Growth with James Chappell of SCbio
JONES DAY TALKS®: The CNPV Pilot Program: FDA's High-Speed Lane for Drug Approval
Hospice Insights Podcast - Endings and Beginnings: Reflections on Meg Pekarske’s 25+ Years as a Hospice Advocate
Health-e Law Podcast, Episode 21 | J.P. Morgan Healthcare 2026 and Beyond: Technology Adoption and Strategic Transformation Under Cost Pressure
Got an Audit Letter? Here’s What Every Health Care Provider Should Do
Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 267: Leading Legal Strategy at a Growing Health System with Kelli Ferry of Novant Health
We get AI for work™: Preparing Real-World Healthcare Environments for an AI-Driven Future
Health-e Law Podcast, Episode 20 | J.P. Morgan Healthcare 2026 and Beyond: How Digital Innovation Shapes Healthcare M&A
Podcast - Minority Deals in Healthcare Private Equity: An Evolving Opportunity for GPs and Founders Counsel That Cares Podcast Series
Pay Transparency + the Power of Preventive Strategies: Episode 3 — Pivoting Toward Preparation in the Life Sciences
Pay Transparency + the Power of Preventive Strategies: Episode 2 — Healthcare Compliance Crossroads
Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 266: Navigating Today’s Healthcare Landscape with Leighton Roper of Maynard Nexsen
Hospice Insights Podcast - Reimagining How We Navigate Change and Loss: A Conversation with Sonya Dolan and Bridget Sumser of Mettle Health
Podcast - The Fast-Growing Wound Care Industry
Key Takeaways - FDA explains what must be “new” to qualify for three years of non-patent market exclusivity. In a new draft Q&A guidance, FDA walks sponsors through what makes a clinical investigation “new,” how to support...more
Key Takeaways - FDA has proposed a Plausible Mechanism Framework for ultra-rare disease therapies. The February 2026 draft guidance explains how sponsors may demonstrate safety and effectiveness when traditional randomized...more
In this episode of Wicked Coin, Diana Shaw and Tatiana Sainati explore one of the most disturbing healthcare fraud schemes in U.S. history: a trusted oncologist who exploited patients’ deepest fears, administering often...more
One of the beneficial characteristics of the response to the COVID -19 pandemic were pledges from companies involved in developing vaccines (such as Moderna, Pfizer, BioNTech, and others) not to enforce patents on relevant...more
Welcome back to The Week in Weed, your Friday look at what’s happening in the world of legalized marijuana. This week, Oklahoma’s governor spoke out in favor of a medical marijuana ballot initiative. Florida will not see...more
On Friday, March 7, 2026, Pennsylvania’s Office of Development Programs (ODP) published final fee schedule rates for supports coordination (SC) and targeted supports management (TSM) services provided under Pennsylvania’s...more
2025 was another busy year for the New Jersey legislature in proposing and finalizing bills impacting health care. In this multipart update, we discuss the new bills and their impact on the healthcare industry in New Jersey....more
In an industry built on precision, pressure, and perfectionism, conversations about mental health often feel like forbidden territory. Yet on a recent episode of Mind Matters, Breaking the Silence in Legal Spaces, hosts Mike...more
On February 23, 2026, FDA issued a highly anticipated draft guidance entitled “Considerations for the Use of the Plausible Mechanism Framework to Develop Individualized Therapies that Target Specific Genetic Conditions with...more
Serent Capital has announced an investment in Saisystems Health. Saisystems, founded in 1987 and based in Shelton, Connecticut, is a provider of revenue cycle management and electronic health record solutions for physicians...more
After the Council and the European Parliament have reached an agreement in the trilogue negotiations on the so-called Pharma Package in December 2025, the texts of the provisional agreement (comprising a new regulation and a...more
A recent investigative reporting by The Wall Street Journal highlights significant concerns within the Medicaid-funded autism therapy sector, particularly Applied Behavior Analysis (ABA). The article details how rapid...more
President Trump’s second term has produced a wave of administrative actions—more than 250 Executive Orders alone have been issued since January 20, 2025. These directives cover a wide range of business critical issues,...more
How in-depth has your entity reviewed its third-party payor agreements? Have your billing team, Compliance Officer, Privacy Officer, and Legal team all been made aware of requirements or, better yet, were they involved in the...more
As we continue to move through 2026, the life sciences landscape is shaped by a convergence of regulatory, enforcement, and market access developments that demand heightened attention from industry stakeholders....more
On March 3, 2026, U.S. Food & Drug Administration (FDA) sent 30 warning letters to telehealth companies that market compounded GLP‑1 products. These letters highlight FDA’s current enforcement priorities in the compounded...more
On March 2, 2026, Judge Patti B. Saris of the District Court for the District of Massachusetts partially ruled in favor of Regeneron Pharmaceuticals on its motion to amend its answer in a qui tam case to assert contingent...more
The U.S. Agency for Toxic Substances and Disease Registry (ATSDR) recently released two new Interaction Profiles for Toxic Chemical Mixtures, continuing a long-running federal effort to better understand the health effects of...more
Alaska AG Stephen Cox issued enforcement warning letters to more than 1,500 tobacco retailers and distributors for allegedly selling unauthorized electronic smoking devices and nicotine pouches in violation of federal and...more
On March 9, 2026, the New York Department of Health (DOH) issued updated guidance for Licensed Home Care Services Agencies (LHCSAs), Medicaid Managed Care Organizations (MMCOs), Certified Home Health Agencies (CHHAs), former...more
Biotech and digital health teams working in Europe sometimes find that the hardest General Data Protection Regulation (GDPR) question in clinical research is not whether the law applies (it does), but how the different views...more
In this briefing, experts from multiple practice areas provide an overview of some of the key UK legal developments from 2025 which companies in the pharmaceutical sector should be aware....more
The United States Postal Service (“USPS”) recently issued a final rule that became effective December 24, 2025 to clarify the definition and application of postmarks. The rule provides that a postmark applied at a USPS...more
Over the past year, the BIOSECURE Act has transitioned from legislative debate to enacted federal law. The significance of this development lies not merely in the fact of enactment, but in the shift it represents: companies...more
Attendees of the Federal Bar Association’s annual Qui Tam Conference gained valuable insights from one of DOJ’s top False Claims Act enforcers last month. Commercial Litigation Branch Deputy Assistant Attorney General Brenna...more
